Crinetics Pharmaceuticals (CRNX) EBT Margin Growth (1y) (2018 - 2026)
Powered by 
Analysis
Crinetics Pharmaceuticals (CRNX) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -392.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 29,565.00 |
| 10 | Crinetics Pharmaceuticals | 8.99 Bn | 8.99 Bn | 24.96 Mn | -1.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.17 Mn |
| Mar 31, 2026 | -2.80 Mn |
| Jun 30, 2025 | -734,415.00 |
| Mar 31, 2025 | 1.64 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 866,750.00 |
| Sep 30, 2023 | 716,428.00 |
| Jun 30, 2023 | -449,280.00 |
| Mar 31, 2023 | 64,319.00 |
| Dec 31, 2022 | 2.35 Mn |
| Mar 31, 2020 | -2.18 Mn |
| Dec 31, 2019 | -345,587.00 |
| Sep 30, 2019 | -147,511.00 |
| Mar 31, 2019 | -122,583.00 |
| Dec 31, 2018 | -59,782.00 |
| Sep 30, 2018 | -100,487.00 |
| Jun 30, 2018 | -64,501.00 |